MAIA Biotechnology
MAIA • AMEX
MAIA Biotechnology is a biotechnology company in the healthcare sector trading on AMEX, led by CEO Vlad Vitoc, with a market cap of $79.5M.
Market Cap$79.5M
Employees13.0
CEOVlad Vitoc
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 8, 2026 · In 3 weeksQ1 2026
Financials
MAIA Biotechnology FAQ
Common questions about MAIA Biotechnology
MAIA Biotechnology is scheduled to report earnings for Q1 2026 on May 8, 2026.
MAIA Biotechnology has approximately 13 employees.